Fujii Satoshi, Muraoka Sanae, Miyamoto Atsushi, Sakurai Koichi
Department of Hospital Pharmacy, Sapporo Medical University Hospital.
Department of Life Science, Hokkaido Pharmaceutical University School of Pharmacy.
Yakugaku Zasshi. 2018;138(1):73-81. doi: 10.1248/yakushi.17-00133.
Cytopenia is a major adverse event associated with linezolid therapy. The objective of this study was to examine whether the cytotoxicity of linezolid to eukaryotic cells was associated with mitochondrial dysfunction and apoptosis-like cell death in human leukemic monocyte lymphoma cell line U937. Apoptosis-like cell death was clearly observed when cells were incubated with linezolid, depending on the duration and linezolid concentration. Mitochondrial membrane potential of cells treated with linezolid collapsed in a short period of time, but the number of mitochondria did not decrease. Cytotoxicity of linezolid was relieved by the knockdown of superoxide dismutase-1 in U937 cells. On the other hand, no autophagy was observed in cells treated with linezolid. These results suggest that mitochondrial damages would be linked to the induction of apoptosis in U937 cells treated with linezolid and that its mechanism does not involve autophagy.
血细胞减少是与利奈唑胺治疗相关的主要不良事件。本研究的目的是检测利奈唑胺对真核细胞的细胞毒性是否与人类白血病单核细胞淋巴瘤细胞系U937中的线粒体功能障碍和凋亡样细胞死亡有关。当细胞与利奈唑胺孵育时,根据孵育时间和利奈唑胺浓度可明显观察到凋亡样细胞死亡。用利奈唑胺处理的细胞的线粒体膜电位在短时间内崩溃,但线粒体数量并未减少。U937细胞中超氧化物歧化酶-1的敲低可减轻利奈唑胺的细胞毒性。另一方面,在用利奈唑胺处理的细胞中未观察到自噬现象。这些结果表明,线粒体损伤与利奈唑胺处理的U937细胞中凋亡的诱导有关,且其机制不涉及自噬。